Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - TOTAL CURRENT LIABILITIES
Total Current Liabilities KALV - KalVista Pharmaceuticals, Inc.
22.8 M
LAST VALUE
40.36%
2 YEAR CAGR
4.79%
5 YEAR CAGR
19.16%
10 YEAR CAGR